Ureaplasma: The Infertility Bacteria Nobody Taught You About

May 18, 2026
abstract microscopic-style illustration of ureaplasma bacteria

Most people have never heard of ureaplasma. That's not because it's rare. It's because nobody told them about it.

Ureaplasma is a type of bacteria. It's one of the most common bacteria in the human reproductive tract, yet it's excluded from every standard STI panel, every routine fertility workup, and most doctor-patient conversations about reproductive health.

If you're trying to conceive—or supporting someone who is—this gap matters. Ureaplasma occupies an unusual gray zone in medicine: it's too common to be called a classic STI, too harmless to trigger universal screening, but too frequently implicated in fertility problems to be ignored.

This article covers what ureaplasma is, how it's transmitted, what symptoms to watch for (spoiler: there often aren't any), how it connects to fertility outcomes for both women and men, how it's tested, and how it's treated when treatment is warranted. The goal isn't to alarm you. It's to give you the information that a standard fertility workup probably won't, so that you can ask the right questions and advocate for a more complete picture of your reproductive health.

Key Takeaways

  • Ureaplasma is extremely common — Found in 40–80% of sexually active women and up to 70% of sexually active adults overall, yet it's absent from standard STI panels and routine fertility testing.
  • Most carriers have no symptoms — The majority of people with ureaplasma are colonized, not infected, and will never experience any symptoms or complications.
  • It can affect fertility when it causes infection — When ureaplasma migrates to the upper reproductive tract, it can trigger endometrial inflammation, disrupt sperm quality, and complicate IVF or IUI procedures.
  • Testing requires a specific ask — Standard cultures often miss it; PCR testing is the preferred method, and both partners should be tested simultaneously.
  • Treatment is straightforward when needed — Doxycycline or azithromycin for both partners, with follow-up testing to confirm eradication. But not every positive test requires treatment.
  • It's worth ruling out for fertility patients — Ureaplasma alone is unlikely to be the sole cause of infertility, but it's a treatable, modifiable factor that's systematically overlooked in standard workups.

What Is Ureaplasma?

Ureaplasma species and Mycoplasma hominis, members of the class Mollicutes, are among the smallest self-replicating and free-living organisms known. They are usually identified as common harmless bacteria in the lower urogenital tract of healthy individuals. Think of them as stripped-down bacteria, so small they sit at the boundary of what can sustain independent life.

What makes ureaplasma tricky comes down to one missing feature: it has no cell wall. That absence means it won't react to a gram stain, won't respond to many common antibiotics, and doesn't show up under a standard light microscope.

Common clinical species include Mycoplasma genitalium (MG), Mycoplasma hominis (MH), Mycoplasma pneumoniae (MP), Ureaplasma parvum (UP) and Ureaplasma urealyticum (UU). These latter two species — Ureaplasma parvum and Ureaplasma urealyticum — are the ones that matter most for reproductive health. They're closely related but carry different risk profiles. A positive test that doesn't differentiate between them can leave you with an incomplete picture.

The most important distinction in any ureaplasma conversation is colonization versus infection. Ureaplasma urealyticum and Ureaplasma parvum are common commensal (meaning "harmless") organisms found in the lower urogenital tracts of many healthy, sexually active adults. In fact, studies have found that upwards of 80% of sexually active women carry ureaplasmas in their vagina, urethra, and/or cervix. Odds are, you do too.

That said, most people who test positive are colonized: The bacteria are present but coexist peacefully with the rest of the microbiome. It's like the bacteria on your skin: There are millions of them, and they're not a problem.

Any shift from harmless colonization to active infection depends on bacterial load, immune status, and whether the bacteria migrate upward (meaning from the cervix or vagina into the uterus and fallopian tubes, or from the urethra into the vas deferens and testes). Either way, that migration is where the trouble starts.

Feature U. urealyticum (UU) U. parvum (UP)
How Common Less common than UP, but more frequently linked to disease More common overall; accounts for the majority of positive results
Where It's Found Lower urogenital tract; can ascend to upper reproductive tract Lower urogenital tract; also found in the upper tract but less studied independently
Fertility Risk Level Higher — more consistently associated with male infertility, endometritis, and adverse pregnancy outcomes Lower — often considered harmless, though high loads may still pose risk
Typical Antibiotic Response Generally responsive to doxycycline and azithromycin; some emerging resistance noted Generally responsive to first-line antibiotics; resistance patterns similar to UU

How Do You Get Ureaplasma?

Genital mycoplasmas are transmitted through vaginal, anal, and oral sexual contact. That's both the primary transmission route, and the reason ureaplasma prevalence correlates with sexual activity and number of partners. The risk of infection increases with the number of sexual partners.

But here's where it gets complicated, and where a lot of confusion and unnecessary shame enters the picture: ureaplasma can be present in people who have had zero or only one sexual partner. UU is found in 40–80% of sexually mature asymptomatic women, in 5% of children, and in 40% of sexually inactive women. That presence in sexually inactive individuals means the full range of transmission isn't yet fully understood.

Can you get ureaplasma without being sexually active? Even though sexual contact is the dominant route, the answer is yes. These bacteria have been identified in non-sexually active individuals and in monogamous couples where neither partner has had outside contact. Mothers can pass it to newborns during pregnancy or delivery, with transmission rates ranging from 25% to 60%, and colonization in infants can linger for months after birth.

Mycoplasma and ureaplasma species are frequently listed among the so-called-harmless microorganisms of the lower genital tract. But their role in other sexually transmitted infections remains unclear. Unlike, say, chlamydia or gonorrhea, ureaplasma is not classified as a classic STI. It sits in a gray zone: Technically transmissible through sexual contact, but too common and too benign to carry the same clinical weight as a traditional sexually transmitted infection.

This isn't herpes or syphilis. You're not going to have visible sores.

What shifts colonization toward active infection? Several factors increase the risk:

  • Weakened immune system — Their existence may be harmless until an individual is in an immunosuppressed state where they can cause various infections.
  • Bacterial vaginosis or microbiome disruption — Colonization of the genital tract by ureaplasma can affect the occurrence of co-infections such as Gardnerella vaginalis.
  • Elevated vaginal pH — Ureaplasma breaks down urea into ammonia, which raises the vaginal pH and disrupts the natural environment.
  • High bacterial load — Concentration matters. Low-level colonization and high-concentration infection carry very different risk profiles
  • Antibiotic disruption of vaginal flora — Colonization has been linked to younger age, lower socioeconomic status, multiple sexual partners, oral contraceptive use, and recent antibiotic treatment.

Symptoms of Ureaplasma — or the Absence of Them

Most ureaplasma carriers have no symptoms at all. Which is exactly why it can go undetected for years.

Many providers write ureaplasma off as normal body flora, so even when it's quietly causing damage, it doesn't trigger the kind of clinical alarm bells that would prompt further investigation.

How long can you have ureaplasma without knowing? Indefinitely. Some people carry it for years—or their entire adult lives—without any indication. Many only discover it during a fertility investigation, after months or years of unexplained difficulty conceiving. Studies indicate that approximately 70% of individuals with ureaplasma are asymptomatic carriers.

When symptoms do appear, they're easy to dismiss, or misattribute entirely. These symptoms may look like a UTI, hormonal change, bacterial vaginosis, or half a dozen other things:

  • Burning or pain during urination
  • Unusual vaginal or urethral discharge
  • Pelvic or lower abdominal pain
  • Itching or discomfort in the genital area

These ureaplasma symptoms do vary by sex. For the two species most commonly found in sexually active adults, M. hominis and U. urealyticum, a significant number of people carry them without any symptoms. Women who do develop symptoms may experience swelling of the cervix (cervicitis), of the uterine lining (endometritis), or signs of pelvic inflammatory disease (PID). Men may notice urethral swelling (urethritis), prostate symptoms, or, like many women, nothing at all.

The fact that ureaplasma can be asymptomatic doesn't mean it's always benign in the fertility context, especially as we age and pregnancy becomes more challenging. When ureaplasma infection goes untreated, it can lead to chronic inflammation of the reproductive tract. This inflammation may interfere with the quality of cervical mucus, embryo implantation, or even sperm-egg interaction. Silent infections can still trigger inflammation in the endometrium or compromise sperm quality without producing a single noticeable day-to-day symptom.

Ureaplasma and Fertility: What the Research Actually Says

This is where we need to be honest about the state of the evidence. The research on ureaplasma and fertility is mixed and emerging. This article won't pretend otherwise. Some studies show a strong association between ureaplasma and fertility problems; others show no significant effect. The goal here is informed understanding, not panic.

For Women

In women (plus non-binary and trans people who have female reproductive systems), ureaplasma can settle in the cervix, uterus, and even the fallopian tubes. If it moves to the upper reproductive tract, it may cause inflammation in the endometrium, which can make it more challenging for a fertilized egg to attach and grow.

The mechanism is relatively straightforward: when bacteria ascend from the vagina and cervix into the uterus and fallopian tubes, they can trigger a chronic inflammatory response. That inflammation can make the endometrial lining less receptive to an embryo, even when everything else looks normal on paper.

Ongoing inflammation in the uterus has been linked to issues like repeated implantation failures, adverse pregnancy outcomes such as early miscarriages, and unexplained infertility.

So colonization of the lower genital tract with mycoplasmas can lead to asymptomatic infections of your upper reproductive system. Sometimes asymptomatic or sparsely symptomatic cervical infections cause complications such as pelvic inflammatory disease (PID), fallopian tube inflammation, fallopian tube obstruction, or even ectopic pregnancies.

There's also a microbiome angle. A relationship was observed between increased vaginal pH values and the presence of ureaplasma. That elevated pH can create conditions where other harmful bacteria thrive, compounding the problem.

For Men

For men (plus nonbinary and trans people with male reproductive systems), ureaplasma can damage sperm in a variety of ways. Sperm motility (swimming) and morphology (shape) both take a hit when infection is present, and DNA damage compounds this problem, lowering the odds of conception. Inflammation in the reproductive tract also drives up oxidative stress in semen, further dragging down sperm quality.

Studies have found that detection rates of ureaplasma in infertile men's semen are higher than in fertile men. But—and this is the big caveat—other studies have shown no significant difference in fertility outcomes between men with and without ureaplasma.

So why the inconsistency? There are probably a few reasons. Bacterial load would seem to matter. Immune response certainly varies between individuals. Co-infections with other organisms can make it difficult to isolate ureaplasma's independent effect. And there may even be a genetic link, where certain people are susceptible to damage, while others are immune.

The truth is, we need to do more research.

But research five or ten years from now doesn't help you today.

So here's some more of what we do know about ureaplasma, and how it can affect your fertility outcomes:

For IVF and IUI

This is where the clinical stakes become concrete. During reproductive healthcare procedures, if ureaplasma is present in a woman's cervical secretions, it can be unintentionally pushed into the uterine cavity. For example, uterine catheters used for embryo transfer (ET) and intrauterine insemination (IUI) must pass through the cervix. This catheter contamination risk—bacteria hitching a ride from the cervix into a normally sterile uterine cavity—is a specific and well-documented concern.

Several scientists have shown a difference in pregnancy rates among patients with ureaplasma infection who were treated with antibiotics and those who were not. But these studies aren't always sucesfully replicated. Other reports have not been able to identify a statistically significant effect from ureaplasma infection across study populations.

Until the final verdict is in regarding the role of ureaplasma on fertility procedures, it may be best to err on the side of caution. After all, you probably don't care what makes a difference across the average population: You care about what will make a difference for you personally.

That's why as a precautionary measure, some fertility clinics now screen and treat for ureaplasma before beginning assistive reproduction procedures. Given that treatment is a simple course of antibiotics, this seems like a reasonable approach. Consider asking your provider about it.

Pregnancy Complications

The evidence is more consistent here. Ureaplasma is known to contribute to adverse pregnancy outcomes. Ureaplasma infection triggers a pro-inflammatory response, leading to an overactive immune system. Studies suggest that ureaplasma infection may contribute to conditions such as spontaneous abortion, preterm birth, premature rupture of membranes (PROM), and postpartum and neonatal infections—albeit probably not to the same degree as other more severe risks.

Weak evidence has been found that directly links U. urealyticum with repeated spontaneous abortion and stillbirth, while much stronger evidence associates it with both chorioamnionitis (infection of the placenta and amniotic fluid) and low birth weight.

A Note on Nuance

Ureaplasma rarely lives alone. Because it tends to show up alongside other bacteria like Mycoplasma hominis and Gardnerella, scientists sometimes describe ureaplasma as an "indicator species." Its presence, especially in high concentrations, may signal a reproductive microbiome that's shifted away from optimal conditions. This combination of colonizers makes it very difficult to isolate ureaplasma's independent effect. But it also means that addressing ureaplasma can be part of restoring a healthier overall environment, with many beneficial knock-on effects.

How Ureaplasma Is Tested

Most standard STI or fertility tests focus on pathogens like Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Ureaplasma and its close relative, Mycoplasma hominis, aren't automatically included because they're common colonizers and can exist without symptoms. If you want to know whether ureaplasma is a factor in your reproductive health, you have to ask for the test. It won't happen on its own.

Who should consider testing? It's not recommended for every healthy adult. But testing can make sense for specific groups:

  • Anyone with unexplained infertility — when standard workups come back "normal" but conception isn't happening
  • People experiencing recurrent pregnancy loss — particularly when no other cause has been identified
  • Those with symptoms of urethritis or PID that don't respond to standard treatment
  • Couples planning IVF or IUI — some clinics already include this as part of pre-procedure screening

Both partners should be tested simultaneously: Treating one partner while the other still carries the bacteria undermines everything.

Detecting ureaplasma usually requires PCR (polymerase chain reaction) testing, which is not the standard culture-based approach most clinics run by default. It's more complicated to do, which means samples usually need to be shipped farther away, results take longer to come back, and overall testing costs more to complete.

There's another diagnostic trap: where you test matters as much as how. Conventional tests like swab cultures or endometrial biopsy (CD138) often miss the infection entirely, and vaginal microbiome testing alone can be misleading, since ureaplasma can be thriving in the uterus while showing up nowhere in the vaginal canal.

If a vaginal swab comes back negative but clinical suspicion remains high, an endometrial sample gives a far more accurate picture of what's actually going on.

Specific sample types depend on the clinical situation:

  • Women — vaginal swab, cervical swab, or endometrial sample (via menstrual blood or biopsy)
  • Men — first-void urine, urethral swab, or semen sample (particularly relevant during fertility evaluation)
Method Sample Type Sensitivity Availability Best For
PCR (Polymerase Chain Reaction) Swab, urine, semen, endometrial sample High — detects bacterial DNA even at low concentrations Widely available at reference labs; may require specific ordering Gold standard for ureaplasma detection; preferred for fertility workups
Specialized Culture Swab, urine, semen Moderate — requires specific growth media; can miss low-load infections Limited to labs with specialized media Confirming viable organisms; antibiotic susceptibility testing
Microbiome Sequencing Vaginal swab, endometrial sample High — identifies full bacterial community Growing availability; used by some fertility clinics Comprehensive view of reproductive microbiome; identifies co-infections
Standard STI Panel Swab, urine Does not detect ureaplasma Universally available Not useful — ureaplasma is not included

Treatment: Antibiotics, Resistance, and Why Both Partners Need to Be Treated

When treatment is warranted, the approach is straightforward, with a few important caveats. Vancomycin and beta-lactam antibiotics are useless against ureaplasma and mycoplasma species because they lack a cell wall. So penicillin, amoxicillin, and their antibiotic cousins are off the table entirely.

First-line treatment is doxycycline — typically 100mg twice daily for 7–14 days. Josamycin, doxycycline, and tetracycline are antibiotics with outstanding activity against UU, UP, and M. hominis. Doxycycline is the most studied option and remains highly effective in North America.

Alternative antibiotics include macrolides, like azithromycin, josamycin, and erythromycin. These become relevant when doxycycline isn't tolerated or is contraindicated (such as during pregnancy, when doxycycline is typically avoided). Azithromycin, in particular, has shown strong efficacy against Ureaplasma urealyticum and is a common alternative in clinical practice.

Antibiotic resistance is real, but not yet dominant. A 2025 study analyzing 415 Ureaplasma isolates from the U.S. and Canada found 61 (14.7%) were resistant to one or more drugs, with resistance rates for erythromycin, tetracycline, and levofloxacin at 2.4%, 6.5%, and 6.7%, respectively. Those numbers are reassuring overall: They suggest that macrolides, tetracyclines, and fluoroquinolones should still be effective against ureaplasma infections.

But it also underscores why follow-up testing matters: because they can be resistant to antibiotics, you shouldn't assume that treatment worked.

Both partners need treatment simultaneously. Treating ureaplasma isn't about addressing the infection in one partner alone. Even after treatment, there's a risk of reinfection if your partner isn't tested and treated in parallel. Reinfection from an untreated partner is one of the primary reasons for treatment failure — and it's entirely preventable.

Post-treatment protocol:

  • Follow-up testing around 3–4 weeks after completing antibiotics to confirm eradication
  • Abstain from barrier-free sex until both partners test negative
  • If the initial antibiotic didn't work, susceptibility testing can guide the choice of an alternative agent

Not every positive test requires treatment. This bears repeating. The clinical decision depends on symptoms, bacterial load, immune status, and reproductive goals. An asymptomatic person with low-level colonization who isn't trying to conceive likely doesn't need antibiotics at all. But someone about to start IVF with a high-load positive result is a different story. Your doctor's guidance (informed by your specific situation) is always the right starting point.

What This Means for Your Reproductive Health Journey

Ureaplasma is unlikely to be the sole cause of infertility in most cases. It's one piece of a much larger puzzle. But it's a treatable piece, and it's one that standard fertility workups routinely miss. That combination — modifiable but overlooked — is precisely what makes it worth investigating.

If you've been told "everything looks normal," but something still doesn't add up, ureaplasma testing is a reasonable next step. You can bring it to your next appointment with specific language: "I'd like to test for ureaplasma and mycoplasma as part of my fertility workup." That's a concrete, evidence-supported request that any reproductive health provider should be able to accommodate.

Ureaplasma is also one example of a broader category of under-investigated factors that contribute to so-called "unexplained" infertility. The vaginal and uterine microbiome, chronic subclinical endometritis, subtle hormonal imbalances — these are all areas where the standard panels stop short. A complete fertility picture often requires going beyond the tests that doctors order by default.

If you're in the where the tests say you're fine but your body tells a different story, myStoria might be able to help. Our mobile app is designed to surface the gaps that standard workups leave behind, connect the threads between symptoms, elevate forgotten test results, and help prompt you with questions about things that could be overlooked. And it's free to get started.

FAQ

What is ureaplasma?

Ureaplasma is a common bacterium found in the genital tract, belonging to the Mycoplasma family. In most people, it's a harmless part of the normal microbiome. But when it overgrows or migrates from the lower genital tract to the uterus or fallopian tubes, it can cause infection and contribute to fertility problems, pregnancy complications, or symptoms like urethritis and pelvic inflammatory disease.

How do you get ureaplasma?

The primary route of transmission is sexual contact (vaginal, oral, or anal). But mother-to-child transmission also occurs, with vertical transmission rates ranging from 25% to 60%, happening in utero or during delivery. Ureaplasma isn't classified as a classic STI because it can be found in non-sexually active individuals too, including some children. The full range of transmission pathways isn't yet completely understood.

Can you have ureaplasma for years without knowing?

Yes. The majority of people carrying ureaplasma (estimated at 70–80%) have no symptoms at all. Some carry it indefinitely without any complications and only discover it during a fertility investigation or screening for recurrent pregnancy loss. Because this testing isn't routine, many people go years without knowing they carry it.

Does ureaplasma always need to be treated?

No. Treatment decisions depend on symptoms, bacterial load, and reproductive goals. Asymptomatic colonization in someone who isn't trying to conceive may not require antibiotics. However, for people with unexplained infertility, recurrent pregnancy loss, or those planning IVF or IUI, many clinicians recommend treatment as a precaution. The intervention is a short course of antibiotics with relatively few side effects. Follow your doctor's guidance based on your specific circumstances.

Can ureaplasma cause miscarriage or preterm birth?

Studies suggest that ureaplasma infection may contribute to conditions such as spontaneous abortion, preterm birth, premature rupture of membranes (PROM), and postpartum and neonatal infections. The association is stronger when bacterial load is high and when the bacteria have ascended to the uterine cavity. That said, many pregnant women carry ureaplasma without any complications. Clinical management depends on individual risk factors, symptoms, and the judgment of your care team.

About the Author

myStoria is a digital fertility partner designed to address the complexities of infertility care. By providing tools for advocacy and support, myStoria helps users reduce the time, cost, and life disruption on their path to parenthood. Founded by a team of individuals who have experienced the challenges of infertility firsthand, myStoria is committed to creating a future where every fertility journey is met with clarity, compassion, and confidence.

myStoria app icon
Stop holding it all in your head.
Download on the App StoreGet It On Google Play
Medical app screen showing a timeline of health story points including appointments, test results, nurse check-in, and diagnosis with dates from December 2025 to February 2026.